Evidence map›Paper›PMID 27312460›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2016

CKD and Muscle Mitochondrial Energetics.

Baback Roshanravan, Bryan Kestenbaum, Jorge Gamboa, Sharon A Jubrias, Ernest Ayers, Laura Curtin, Jonathan Himmelfarb, Ian H de Boer, Kevin E Conley

Abstract readLetter
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Baback RoshanravanUniversity of Washington Kidney Research Institute, Seattle, Washington. Electronic address: broshanr@u.washington.edu.
Bryan KestenbaumUniversity of Washington Kidney Research Institute, Seattle, Washington.
Jorge GamboaVanderbilt University Medical Center, Nashville, Tennessee.
Sharon A JubriasUniversity of Washington, Seattle, Washington.
Ernest AyersUniversity of Washington Kidney Research Institute, Seattle, Washington.
Laura CurtinUniversity of Washington Kidney Research Institute, Seattle, Washington.
Jonathan HimmelfarbUniversity of Washington Kidney Research Institute, Seattle, Washington.
Ian H de BoerUniversity of Washington Kidney Research Institute, Seattle, Washington.
Kevin E ConleyUniversity of Washington, Seattle, Washington.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI JOSHUA P THALER · 1986 to 2026
$30.4M
Oxidative Stress in Chronic Kidney DiseaseR01HL070938 · NHLBI · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, IKIZLER, TALAT ALP · 2003 to 2012
$3.2M
Skeletal Muscle Mitochondrial Function in Chronic Kidney DiseaseR01DK101509 · NIDDK · UNIVERSITY OF WASHINGTON · PI KESTENBAUM, BRYAN R · 2015 to 2018
$2.5M
Insulin Resistance in Chronic Kidney DiseaseR01DK087726 · NIDDK · UNIVERSITY OF WASHINGTON · PI DE BOER, IAN H · 2010 to 2013
$1.9M
Skeletal muscle dysfunction in persons with chronic kidney diseaseK23DK099442 · NIDDK · UNIVERSITY OF WASHINGTON · PI ROSHANRAVAN, BABACK · 2013 to 2017
$777k
Mitochondrial Dysfunction in Chronic Kidney DiseaseK23DK100533 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAMBOA, JORGE LUIS · 2013 to 2017
$763k
Midcareer Investigator Award: Metabolic Complications of Chronic Kidney DiseaseK24DK103986 · NIDDK · UNIVERSITY OF WASHINGTON · PI KESTENBAUM, BRYAN R · 2016 to 2020
$637k
NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR002319NHLBI NIH HHS R01 HL070938NIDDK NIH HHS K23 DK099442NIDDK NIH HHS K23 DK100533NIDDK NIH HHS K24 DK103986NIDDK NIH HHS L30 DK099909NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK087726NIDDK NIH HHS R01 DK101509
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Energy MetabolismOxygen ConsumptionAdenosine TriphosphateAdultAgedCase-Control StudiesFemaleHumansMagnetic Resonance SpectroscopyMaleMiddle AgedMitochondria, MuscleMuscle, SkeletalOptical ImagingRenal Insufficiency, ChronicSpectrum AnalysisAdenosine Triphosphate

Identifiers

PMID27312460
PMCPMC5063821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.